Filing Details
- Accession Number:
- 0001209191-20-010534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-19 16:31:48
- Reporting Period:
- 2020-02-17
- Accepted Time:
- 2020-02-19 16:31:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 3,128 shares | Avg. Price: $243.67 | Total Value: $762,200.76 |
| Number of Shares After Transactions: | 34,346 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-17 | 2,496 | $241.50 | 37,474 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2020-02-18 | 400 | $241.80 | 37,074 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 1,010 | $242.62 | 36,064 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 530 | $243.66 | 35,534 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 632 | $244.87 | 34,902 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-18 | 556 | $245.57 | 34,346 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $241.80 (range $241.24 to $242.23).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $242.62 (range $242.24 to $243.21).
- Open market sales reported on this line occurred at a weighted average price of $243.66 (range $243.24 to $244.15).
- Open market sales reported on this line occurred at a weighted average price of $244.87 (range $244.28 to $245.26).
- Open market sales reported on this line occurred at a weighted average price of $245.57 (range $245.28 to $245.86).
Billionaire Hedge Funds
